Tag: compound

Presenting GC-MS Results in a Publication

Gas chromatography-mass spectrometry (GC-MS) is a tool that is used to separate, quantify, and analyze organic compounds that are naturally volatile. This article describes how to interpret and present GC-MS results in a publication, for all purposes. HPLC chromatogram of common food additives. Chromatos | Shutterstock. Understanding GC-MS Gas chromatography is used to separate the

Compound improves social interaction in autism mouse model

Children with autism often find social interactions awkward, leaving them isolated. Now in a study appearing in ACS’ Journal of Medicinal Chemistry, scientists report that they have discovered a first-of-its-kind compound that promotes social interaction among laboratory mice that display autistic traits. The finding could lead to the development of drugs capable of improving social

New compound targets drug-resistant HIV mutants

Antiretroviral therapies have worked wonders suppressing HIV replication and its progression to AIDS, but their effectiveness is deteriorating due to the constant development of drug resistance in the virus. Now Yale researchers have shown their newly developed compounds maintain anti-HIV activity against drug-resistant mutants better than FDA-approved medications. The new compounds work by inhibiting the

New compound shown to be as effective as FDA-approved drugs against life-threatening infections

Purdue University researchers have identified  a new compound that in preliminary testing has shown itself to be as effective as antibiotics approved by the Food and Drug Administration to treat life-threatening infections while also appearing to be less susceptible to bacterial resistance. The compound, called F6, has been potent against antibiotic-resistant pathogens such as methicillin-resistant

Researchers use spider venom compound to treat paralysis

A team of Russian scientists together with foreign colleagues, reports that the venom of the crab spider Heriaeus melloteei may be used as a basis for a treatment against hypokalemic periodic paralysis. This disease is caused by genetic mutation that leads to the occurrence of the so-called ω-currents, or leakage currents, via voltage-gated ion channels